Abstract
Trial in progress: A phase two trial of nirogacestat, a gamma-secretase inhibitor, in patients with recurrent ovarian granulosa cell tumors (NCT05348356) (1284)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have